West Ujimqin Banner, Xilingol League, Inner Mongolia, China sales9@alchemist-chem.com 1531585804@qq.com
Follow us:



Phospholipase A2 (PLA2): A Closer Look at Its Journey, Properties, and Prospects

Historical Development

Phospholipase A2 came to prominence through investigations into snake venom during the early twentieth century. Researchers hunting for ways to demystify mechanisms behind envenomation zeroed in on a family of enzymes capable of breaking down cell membranes. Long before the age of targeted therapeutics, the notion of using or inhibiting PLA2 in human disease felt outlandish. Still, growing evidence from biochemistry labs pointed out its role in inflammation, cell signaling, and even the progression of certain diseases. Later on, the discovery that humans harbor different PLA2 isoforms in their platelets, pancreas, and immune tissues awoke pharmaceutical curiosity, turning what was once a “venom toxin” into a subject of biotech fascination.

Product Overview

Modern biotech and pharma industries look to PLA2 as both a target and a tool. Available as highly purified powders, recombinant proteins, or enzyme solutions, PLA2 gets harvested from sources including porcine pancreas, honeybee venom, and E. coli, each with unique amino acid signatures and catalytic quirks. These enzymes catalyze the hydrolysis of the sn-2 fatty acyl bond in phospholipids, releasing fatty acids such as arachidonic acid, a precursor for crucial inflammatory mediators. With formulations dialed in for laboratory research, medical diagnostics, and food processing, manufacturers include technical sheets reporting activity units per milligram, protein content, and purity based on SDS-PAGE or UPLC data.

Physical & Chemical Properties

PLA2 features as a relatively small protein, depending on origin, typically ranging from 12 to 18 kilodaltons. At room temperature, it often appears as a lyophilized white powder, easily soluble in buffered saline solutions at physiological pH. The isoelectric point varies among isoforms, but usually lands between pH 4.0 and 6.5, while optimal activity calls for the presence of calcium ions. Stability holds up well at minus twenty degrees Celsius but falters with repeated freeze-thaw cycles. Under the microscope, PLA2 maintains a tightly coiled polypeptide chain held by disulfide bonds, sensitively reacting to high heat or denaturants such as urea.

Technical Specifications & Labeling

Quality control matter greatly in enzyme application. PLA2 typically comes labeled with source organism, EC number (3.1.1.4), protein content, purity level, and specific activity—measured in international units (IU/mg). Detailed COAs (certificates of analysis) mention recommended storage conditions, expiration date, and batch traceability. Some labs insist on additional tests such as heavy metal content, bacterial endotoxin levels, and host cell protein contamination. Labeling standards, shaped by regulatory bodies like the FDA and EMA, want both transparency and hygiene, ensuring no cross-reactivity in sensitive research contexts.

Preparation Method

The journey to pure PLA2 starts with extraction or recombinant expression. For animal-derived PLA2, purification involves salt precipitation, chromatographic separation—usually ion exchange and gel filtration—plus constant checks of enzyme activity using colorimetric or fluorometric substrates. Recombinant production requires splicing PLA2 cDNA into vectors, inserting these into E. coli or yeast culture, and inducing expression. After harvesting, lysis and purification follow, sometimes calling for refolding from inclusion bodies using step-wise dialysis. Specialist labs may immobilize PLA2 on solid supports for reuse in industrial settings or diagnostic kits.

Chemical Reactions & Modifications

PLA2’s job sounds simple—hydrolyze phospholipids at the sn-2 position—but its chemistry weaves into a host of biological and synthetic processes. Inhibitors like methyl arachidonyl fluorophosphonate help dissect structure-activity relationships. Labeling PLA2 with biotin or fluorescent tags allows researchers to trace movements within cells or tissues. Some modifications engineer cysteine mutants for improved thermostability or altered substrate recognition. In industrial work, site-directed mutagenesis can broaden PLA2’s substrate range, turning it from a finicky research tool into a robust biocatalyst.

Synonyms & Product Names

The enzyme turns up in catalogs under names like ‘phosphatidylcholine 2-acylhydrolase’, ‘secretory phospholipase A2’, and ‘pancreatic lipase’. Manufacturers market specific variants, such as PLA2 Type I, II, V, or X, tailored for applications ranging from food emulsification to immunological research. Labs often nickname products based on species of origin—a common shorthand for anticipated catalytic quirks or glycosylation patterns.

Safety & Operational Standards

Because PLA2 can break apart mammalian cell membranes, safe handling never slips as an afterthought. Lab protocols call for gloves, eye protection, and fume hoods during preparation or manipulation. Inhalation or contact with skin may provoke allergic responses or local irritation. Out of caution, some shops categorize PLA2 as a sensitizer, referencing research linking enzyme exposure to occupational asthma among workers using animal-derived extracts. Disposal flows into biohazard channels, especially for PLA2 sourced from venom or recombinant systems flagged for antibiotic resistance.

Application Area

PLA2 shapes research and industry in ways that stretch far past textbooks. Diagnostic labs use the enzyme in kits that quantify lipid levels or test for pancreatic function in blood samples. Food scientists tap microbes expressing PLA2 to tweak cheese ripening, boost flavor in baked goods, or improve the mouthfeel of low-fat products. Drug developers eye the enzyme as a marker or modulator for diseases ranging from arthritis to cardiovascular inflammation. PLA2’s role in cell membrane remodeling even touches regenerative medicine, underpinning work on engineered tissues or slow-release drug platforms.

Research & Development

In academic labs, PLA2 earns funding for its knack in shaping local inflammation, bridging biochemistry with immunology. Studies link abnormal PLA2 levels with neurodegenerative disease, asthma, and cancer. Efforts to build small-molecule inhibitors or monoclonal antibodies target PLA2 both as a culprit and as a biomarker. On the biotech side, advances in gene editing and protein engineering churn out PLA2 mutants with custom stability, catalytic speed, or substrate tolerance. Each iteration unlocks new diagnostics, from rapid cardiac panels to lipid nanoparticle studies crucial in mRNA vaccine delivery.

Toxicity Research

Toxicologists caution that PLA2’s destructive power crosses well beyond basic lipid mining. High doses or chronic exposure damages cellular membranes, driving necrosis or apoptosis. In some animal studies, PLA2 activity unleashes cascades of eicosanoids, intensifying inflammation, pain, or edema. Researchers zero in on immune modulation, tracking how PLA2 triggers or suppresses cytokine storms. Understanding these dangers gives rise to safer industrial handling and newer antidotes for venom or chemical exposure, with animal testing informing both environmental and medical policies.

Future Prospects

Growing interest in precision medicine and sustainable bioprocessing positions PLA2 for an outsized role in future technology. With the momentum behind lipidomics and cell therapy, new generations of recombinant PLA2 unlock smarter diagnostics and gentler therapies. Artificial intelligence models help map out structure-function relationships, speeding the hunt for next-gen inhibitors or designer biocatalysts. As societies move toward greener chemistry, engineered PLA2 enzymes offer low-energy routes for breaking down or recycling phospholipid-rich waste. Researchers also anticipate uncovering novel isoforms from extremophile organisms, expanding the landscape for discovery and industrial application. Progress follows the twin tracks of public health and environmental stewardship, promising that PLA2 will keep making headlines across fields for years to come.




What is Phospholipase A2 (PLA2) used for?

What Is Phospholipase A2?

Phospholipase A2, or PLA2, shows up in more headlines lately as researchers look for smarter ways to deal with food production, health, and even environmental science. This is an enzyme, meaning it speeds up certain chemical reactions. PLA2’s main trick: it chops up phospholipids, the fat-based building blocks that keep membranes in cells stable. This enzyme works like a pair of scissors, slicing off a fatty acid chain from phospholipids. In plain terms, it helps tweak fats into useful parts, and that opens up all sorts of uses.

PLA2 in Food Production

Baking and dairy manufacturing both rely on fats behaving the right way. Bread companies aim for softness and long shelf-life, and cheese makers strive for better texture and melt. PLA2 steps in by improving how fats and water interact. Breads get fluffier, stay fresher, and resist that weird rubbery texture. Cheese turns out creamier, and spreads blend more evenly. I’ve watched how incorporating PLA2 lets small bakeries compete with larger chains just by boosting bread quality and consistency.

Finding Its Place in Medicine

Hospitals and clinics take an interest in PLA2 for very different reasons. Blood tests use PLA2 to help spot conditions like heart disease or inflammation. PLA2 levels spike when blood vessels swell or get clogged, so measuring the enzyme helps predict risks that doctors can’t always catch by looking at cholesterol alone. Some researchers explore using PLA2 in studying neurodegenerative diseases or cancer, since it can signal when the body’s response to threats goes off track. With stroke and heart attack still leading causes of death worldwide, these clues let specialists step in earlier and save lives.

Stepping Into Research and Technology

PLA2 also works as a lab tool. Scientists who break down cell membranes or study cell signaling rely on PLA2 to get clean results. Biology classrooms use it to show students how membrane chemistry works. Drug companies try to block PLA2 activity sometimes, since it plays a part in pain and swelling. I remember reading how certain anti-inflammatory drugs aim to target PLA2 pathways, hoping to lower harmful side effects tied to older medications.

Hurdles and Solutions

Wide use of PLA2 raises questions. Too much can trigger overactive immune responses or signal inflammation that damages healthy tissue. Overuse in food or medicine risks unknown long-term problems. Regulators and research teams set safety limits, and companies run studies before using PLA2 in anything people eat or drink. They also track where enzymes come from—microbes, plants, or animal products—to catch allergies or contamination early. Interest in plant-based and non-GMO enzyme sources keeps growing, which brings more trust and fewer headaches for people with special diets.

Balancing Promise with Responsibility

PLA2’s story covers kitchens, clinics, labs, and factories. It gives the food industry better tools, helps doctors spot serious health problems, and powers research breakthroughs. At the same time, every new use brings a call for careful oversight. Balancing these interests calls for honest testing, clear communication, and real accountability. By keeping the process open and focusing on public trust over quick gains, everyone benefits from the possibilities that PLA2 brings to the table.

How does Phospholipase A2 (PLA2) work?

Cutting Through the Science

Phospholipase A2 goes wherever cells build or repair their membranes. This enzyme knows how to break down certain fats in those membranes—phospholipids. Every cell lines itself with these compounds; they work as both a barrier and a gatekeeper for traffic in and out of the cell. Our bodies rely on enzymes like PLA2 to manage this process, cleaning up old phospholipids and making way for new ones.

PLA2 slices off one of the fatty acid “tails” from a phospholipid. What’s left becomes lysophospholipid, and the free fatty acid, often arachidonic acid, floats away. I see the consequences every time inflammation shows up—whether in a swollen ankle or seasonal allergies. That’s because this fatty acid forms the building block for messenger molecules that tell our bodies, "It’s time to defend yourself."

The Role in Health and Disease

A little inflammation helps us heal, no question. But too much, for too long, ends up causing pain and tissue damage. Arthritis patients feel this up close. Overactive PLA2 can amplify pain signals and drive swelling, all through those messages it unleashes. Research points to higher PLA2 activity in atherosclerosis, Alzheimer’s, and some forms of cancer as well. Scientists often test blood for PLA2 levels when trying to predict cardiovascular risk.

PLA2 does not act alone. It depends on calcium to fire up, and teams up with other proteins inside or outside cells. Cells lining blood vessels, immune cells fighting infections, and brain cells under stress—all crank out more PLA2 when things go wrong. In normal doses, it helps mop up cell debris and signals help when the tissue suffers injury. Without it, the immune system misses critical cues; too much, and damage spreads.

Everyday Experience Meets Molecular Detail

Growing up in a family full of cooks, I found it interesting how a little oil breaks food apart in a pan and creates new flavors during cooking. PLA2 pulls off a similar trick in our bodies, churning through fat in just the right places to keep everything fresh. So many chronic diseases pass through this same pathway—directing fat traffic and signaling repairs.

Snake bites show one of the extremes. Venom often contains strong PLA2, which shreds cell membranes and causes injury fast. Scientists learned from snakes and built drugs that block aberrant PLA2 activity, hoping to ease suffering in heart attacks and autoimmunity. Our own bodies keep PLA2 in check with balancing molecules and inhibitor proteins. Diet, stress, even pollution can tip this balance, sometimes with lasting consequences for cell health.

Practical Solutions and Outlook

Research keeps pushing for ways to target PLA2 without shutting down good inflammation. Diet rich in omega-3 fatty acids—the stuff famously found in fish—seems to cool excessive PLA2 action. Some new drugs seek to interfere with the enzyme directly, while others try to block the signals after the fact.

Most doctors and researchers agree: monitoring and fine-tuning PLA2 matters, especially as chronic disease rates rise. Until medicine evolves further, habits like reducing processed foods, staying active, and getting enough sleep all help our bodies keep PLA2 right where it belongs.

What are the storage conditions for Phospholipase A2 (PLA2)?

Why Storage Hits Close to Home

Every scientist knows that Phospholipase A2 doesn’t behave like table salt or store-bought vitamins. I’ve watched experiments fall apart after what seemed like harmless neglect in the lab. Months of enzyme work ended in the trash after a single mistake with PLA2. If you want this enzyme to work at its best, giving storage the same effort as protocol is non-negotiable.

Temperature’s Silent Effect

PLA2 belongs in the freezer, simple as that. Long-term, it holds up best at -20°C. Some go lower, pulling out all stops with -80°C. In my experience, those lower temps make the difference if you stock up for months. Leave PLA2 at room temperature for even a day, and you risk getting a faint activity strip where you need a bold band. Research, such as what’s published in enzyme stability studies in Biochemistry journals, backs this up: even a week at 4°C kicks off unwanted degradation. Enzyme activity drops, and precious funds vanish with it.

The Trouble with Thawing

Once you’ve taken PLA2 out for use, it hates going through cycles of freezing and thawing. Each round chips away at stability. The science here is straightforward—multiple studies point to protein denaturation when exposed to fluctuating temperatures. In practical terms, just split that first stock solution into single-use aliquots. I keep a box of labeled tubes ready, so the main vial stays untouched. That routine saved me plenty of headaches with failed controls and wasted kits.

Buffer and Contamination Count

Poor storage isn’t just about temperature. Keeping PLA2 in the proper buffer protects it from unwanted breakdown. I’ve seen labs dissolve it in water alone—activity predictably plummets. Reliable sources recommend buffers like Tris or phosphate at pH 7–8, with stabilizers such as glycerol or BSA thrown in. Even a simple act like opening a vial with contaminated gloves can introduce proteases or bacteria. A moment’s slip contaminates the entire stock, spiking unwanted reactions, and leaving you wondering why results went sideways.

The Real Cost of Getting Casual

PLA2 isn’t a cheap item off the shelf. Schools and hospitals both invest heavily, and wasted enzyme means wasted budgets. Problems start small—weak data, confusing blanks—then snowball into failed projects. The same applies in industry; enzyme batches are tools and investments, not commodities. Each vial sitting outside the cold chain costs lab teams time, grant funds, and progress toward therapies or papers. Multiply that by dozens of labs every year, and you’re staring at massive lost potential.

Building Good Habits

Some fixes are simple, but often overlooked. Post big labels with temperature reminders on freezers, and schedule regular checks. Push for single-use aliquots standard in your group, and write down the dates when you first break the factory seal. Use freshly calibrated fridges. Check the power supply—one blackout can mean ruined batches. Giving junior researchers clear checklists pays off too; I’ve seen fresh lab members catch mistakes the seniors almost missed. These steps take minutes, but they extend enzyme shelf life and boost confidence in every experiment.

Looking Ahead

Making PLA2 last means looking beyond labels and hand-me-down tips. Draw from solid research, real-world experience, and a practical eye for details. Treat storage not as a footnote but as the foundation for every result—and the rest of the workflow benefits. Enzyme science didn’t get this far by ignoring what seems routine, and neither should the current generation of scientists aiming for reliable breakthroughs.

Is Phospholipase A2 (PLA2) safe to use in research applications?

Digging Into Phospholipase A2’s Role

Phospholipase A2 (PLA2) does more than just help scientists understand cell membranes. This enzyme breaks down phospholipids, releasing fatty acids and lysophospholipids. Researchers studying inflammation, neuroscience, and metabolic conditions often rely on this tool to break open new questions in their experiments. PLA2’s key role in releasing arachidonic acid—the starting point for prostaglandins and leukotrienes—gives researchers a direct line to pathways behind everything from allergy attacks to cancer.

PLA2 Doesn’t Work In Isolation

Pulling out a vial of PLA2, folks in the lab sometimes overlook its roots. Found in snake venom, bee stings, and even some bacteria, this enzyme can take a living system apart if misused. Some PLA2 types destroy cell membranes so quickly that just a milligram mishandled can send a researcher or animal model into big trouble. Those stories about lab mishaps and animal welfare teams racing in? PLA2 is a frequent headline.

Lab Safety No One Can Skip

It doesn’t take much to remind you how potent imported enzymes can be. I’ve seen new students in a med school lab reach for PLA2 without thinking about the gloves they’re wearing or whether a fume hood’s running. Even in powder or stock solution, PLA2 can irritate skin, eyes, and lungs. Accidental injection or splash exposure means a trip to the nurse or even the hospital. No bench partner’s going to ignore that warning poster on the wall for long.

Safety Data Sheets Aren’t Optional Reading

PLA2 ships with a Safety Data Sheet (SDS) for a reason. This sheet isn’t busy work from the supplier; it spells out exactly what to do if your elbow knocks over an open tube. PLA2 can trigger allergies, damage tissues, and in concentrated form, affect nerves or blood. It’s tempting to skip this kind of reading, especially under pressure, but cutting corners can shut down a whole research wing.

Best Practices for Teams

Safe research starts with practical training. Gloves, eye protection, and lab coats are the bare minimum. Working inside a biosafety cabinet adds another layer of protection, as does proper waste disposal. Triple-check labeling every single time. Cross-contamination scrambles results and could put others at risk, so a culture of speaking up matters more than any personal embarrassment.

Transparency in Reporting and Supervision

Every institution ought to spell out PLA2 handling rules and keep staff up to date. Reporting exposures, even near-misses, helps spot where protocols break down. One time, a team I knew gave feedback for updating training videos after an accident—the openness improved everyone’s awareness over the next months. Ongoing supervision, spot checks, and even casual peer support can keep the safety culture from going stale.

Balancing Innovation and Safety

PLA2 remains a strong tool for dissecting disease mechanisms and cell biology. Its risks don’t outweigh its benefits if handled with respect and discipline. Scientists who trust the process, share facts, and call out unsafe shortcuts will not only protect each other—they’ll keep their discoveries on track and usable for years to come.

What is the recommended concentration or dosage for Phospholipase A2 (PLA2) experiments?

Digging Into PLA2 Dosage

Lab work with Phospholipase A2 (PLA2) asks for a careful touch. Picking that sweet spot for concentration shapes your whole experiment. Through my own projects and chats with others in cell biology, I've realized how a misplaced decimal can throw data off for weeks. Most studies with purified PLA2 land between 0.1 to 10 micrograms per milliliter (μg/mL). The low end works for in vitro enzyme assays or cell culture models, especially when you watch for subtle changes in lipid breakdown. Move up to the higher end and things get intense: you'll want that for robust hydrolysis or signaling studies that need heavy stimulation.

Why Getting the Dose Right Matters

PLA2 packs a punch even at low doses. It chops up phospholipids, releasing fatty acids and lysophospholipids, sparking cascades in inflammation, cell death, or signaling. Scale up the dose too much, and you risk cellular toxicity. I’ve watched colleagues lose weeks of cell line work after getting careless, causing non-specific cell death. Finding a concentration that triggers your pathway without pushing cells off a cliff matters both for science and the bottom line.

Digging Up The Numbers

PLA2 work often begins with titration. Starting small and scaling up has saved me from repeating full plates. A common start point runs at 0.5 μg/mL for most cell biology or biochemistry experiments. Researchers in lipidomics sometimes dial in as low as 100 nanograms per mL to spot nuanced patterns of lipid release. Immunology labs examining inflammation in animal models often start between 1 and 5 μg/mL based on the nature of the tissue and goals. I’ve found real benefit setting up a quick pilot curve: run concentrations from 0.1, 0.5, 1, 2.5, up to 10 μg/mL with a good control. Watch for specific activity, then decide where true biological effects appear, not just generic cell damage.

Sources and Types Make a Difference

PLA2 comes in flavors: bee venom, snake venom, porcine pancreas, and recombinant human. Each acts with a unique kick and may differ in purity or activity units. Bee and snake venom forms often behave more potently than recombinant or mammalian versions. I once compared bee venom PLA2 to a recombinant version; the former needed less than half the mass for the same lipid hydrolysis in my membrane studies. Always cross-check the specific activity from the data sheet and recalculate dosages when swapping lots or vendors. Never trust a one-size-fits-all number.

Focusing on Controls and Solutions

Another lesson the hard way: batch quality differs. One vendor’s “1 unit/mg” isn’t always another’s. Run a blank and a vehicle control: that means test solvent, buffer, or carrier protein alone. Include a heat-inactivated PLA2 control if possible, so any observed effect traces to enzyme activity. If sticking to published protocols, confirm that someone saw genuine enzyme action at their reported dose using the same source you use, not just a close cousin. Keeping an enzyme stock at -80°C and avoiding repeated freeze-thaw cycles helps because activity drifts with improper storage.

Responsible Science With PLA2

Design experiments with care, trust pilot studies, and keep up with the latest peer-reviewed data. The stakes are high; PLA2 influences key steps in inflammation, neurodegeneration, and even cancer. Getting the dosage right isn’t just about clean results; it respects research funding and lab safety. Every time I invest effort in solid pilot work and thoughtful controls, the payback comes in reproducible, believable data.

Phospholipase A2 PLA2
Names
Preferred IUPAC name phospholipase A2
Other names Phosphatidylcholine 2-acylhydrolase
Phosphatidase
Phospholipase A2
PLA2
Pronunciation /ˌfɒs.foʊˈleɪ.peɪs ˈeɪ tuː/
Preferred IUPAC name phospholipase A2
Other names PLA2
Phosphatidylcholine 2-acylhydrolase
Phospholipase A2 group IIA
Secretory phospholipase A2
sPLA2
Pronunciation /ˌfɒs.foʊ.lɪˌpeɪs eɪ tuː/
Identifiers
CAS Number 9001-84-7
Beilstein Reference 1712804
ChEBI CHEBI:83444
ChEMBL CHEMBL2040
ChemSpider 10479897
DrugBank DB00035
ECHA InfoCard 03bfc1bb-031f-4b43-85cd-0cd70e6f035b
EC Number 3.1.1.4
Gmelin Reference 89547
KEGG K01047
MeSH D010718
PubChem CID 16326377
RTECS number MU9278000
UNII YW5D01PMX9
UN number UN3272
CompTox Dashboard (EPA) DTXSID3021327
CAS Number 9001-84-7
Beilstein Reference 3463110
ChEBI CHEBI:8386
ChEMBL CHEMBL204
ChemSpider 8821076
DrugBank DB00035
ECHA InfoCard 03c7f92a-5d2b-4d56-921e-8ccaaa85c276
EC Number 3.1.1.4
Gmelin Reference 82268
KEGG ec:3.1.1.4
MeSH D010718
PubChem CID 71856
RTECS number RTECS number: SG1860000
UNII R9O6653DGI
UN number UN2810
CompTox Dashboard (EPA) DTXSID7030712
Properties
Chemical formula C229H368N60O68S2
Molar mass 13710 g/mol
Appearance White or light yellow powder
Odor Characteristic
Density ~1.2 g/cm³
Solubility in water Slightly soluble
log P -4.0
Vapor pressure Negligible
Acidity (pKa) 4.6
Basicity (pKb) 7.59
Magnetic susceptibility (χ) -20.5×10⁻⁶ cm³/mol
Viscosity Viscous liquid
Dipole moment 10.3 D
Chemical formula C2299H3552N672O701S16
Molar mass 13776 Da
Appearance White to off-white lyophilized powder
Odor Characteristic
Density 1.3 g/cm³
Solubility in water Soluble
log P -1.6
Acidity (pKa) 5.6
Basicity (pKb) 7.6
Magnetic susceptibility (χ) -20.5 × 10⁻⁶ cm³/mol
Refractive index (nD) 1.480
Viscosity Viscous liquid
Dipole moment 4.7 D
Thermochemistry
Std molar entropy (S⦵298) 474 J/mol·K
Std molar entropy (S⦵298) 310 J/(mol·K)
Pharmacology
ATC code V03AB33
ATC code V03AB36
Hazards
Main hazards May cause allergy or asthma symptoms or breathing difficulties if inhaled.
GHS labelling GHS02, GHS07, GHS08
Pictograms GHS05,GHS07
Signal word Warning
Hazard statements H317: May cause an allergic skin reaction.
Precautionary statements Precautionary statements: P261, P272, P280, P302+P352, P304+P340, P305+P351+P338, P312, P333+P313, P337+P313, P362+P364
NFPA 704 (fire diamond) 1-2-0
Lethal dose or concentration LD50 (rat, intravenous): 300 µg/kg
LD50 (median dose) LD50 (median dose) of Phospholipase A2 PLA2: 1.7 mg/kg (intravenous, mouse)
NIOSH MFCD00151579
PEL (Permissible) Not established
REL (Recommended) 0.01 mg/m³
IDLH (Immediate danger) Not established
Main hazards May cause an allergic skin reaction. Causes serious eye irritation.
GHS labelling GHS05, GHS07
Pictograms GHS05,GHS07
Signal word Warning
Hazard statements H317: May cause an allergic skin reaction.
Precautionary statements Wash hands thoroughly after handling. IF ON SKIN: Wash with plenty of water. If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
NFPA 704 (fire diamond) Health: 2, Flammability: 0, Instability: 0, Special: -
Lethal dose or concentration LD50 (mouse, intravenous): 0.07 mg/kg
LD50 (median dose) LD50: 1.2 mg/kg (intravenous, mouse)
NIOSH Not listed
PEL (Permissible) PEL (Permissible Exposure Limit) for Phospholipase A2 PLA2: "Not established
REL (Recommended) 5 μg/mL
IDLH (Immediate danger) Not established
Related compounds
Related compounds Phospholipase A1
Phospholipase B
Phospholipase C
Phospholipase D
Snake venom phospholipase A2
Secretory phospholipase A2
Cytosolic phospholipase A2
Lysophospholipase
Lipase
Arachidonic acid
Related compounds Phospholipase A1
Phospholipase B
Phospholipase C
Phospholipase D
Pancreatic lipase
Leukocyte elastase
Arachidonic acid
Lysophospholipase